Sixth Street Partners Management Company »

BioMarin Pharmaceutical shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $93M 1.6M 57.22

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding BioMarin Pharmaceutical

BlackRock
Dodge & Cox
PRIMECAP Management Company
Vanguard Capital Management
Vanguard Portfolio Management
Norges Bank Investment Management
Viking Global Investors
State Street Corporation
Vestal Point Capital
AQR Capital Management
FMR
Dimensional Fund Advisors
Geode Capital Management
Capital Research Global Investors
Deep Track Capital

View all funds holding BioMarin Pharmaceutical